nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium Tetradecyl Sulfate—Local reaction—Valrubicin—urinary bladder cancer	0.081	0.108	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—prostate gland—urinary bladder cancer	0.0555	0.219	CbGeAlD
Sodium Tetradecyl Sulfate—Extravasation—Carboplatin—urinary bladder cancer	0.0476	0.0637	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—seminal vesicle—urinary bladder cancer	0.0469	0.186	CbGeAlD
Sodium Tetradecyl Sulfate—Necrosis—Mitomycin—urinary bladder cancer	0.0394	0.0527	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—renal system—urinary bladder cancer	0.0378	0.15	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—urethra—urinary bladder cancer	0.0372	0.147	CbGeAlD
Sodium Tetradecyl Sulfate—Extravasation—Mitomycin—urinary bladder cancer	0.0354	0.0474	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Mitomycin—urinary bladder cancer	0.0327	0.0437	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—female reproductive system—urinary bladder cancer	0.0303	0.12	CbGeAlD
Sodium Tetradecyl Sulfate—PROS1—vagina—urinary bladder cancer	0.0274	0.108	CbGeAlD
Sodium Tetradecyl Sulfate—Local reaction—Fluorouracil—urinary bladder cancer	0.0232	0.0311	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Thiotepa—urinary bladder cancer	0.0178	0.0238	CcSEcCtD
Sodium Tetradecyl Sulfate—PROS1—lymph node—urinary bladder cancer	0.0177	0.0701	CbGeAlD
Sodium Tetradecyl Sulfate—Necrosis—Fluorouracil—urinary bladder cancer	0.0164	0.0219	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Cisplatin—urinary bladder cancer	0.0155	0.0208	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Gemcitabine—urinary bladder cancer	0.015	0.0201	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Fluorouracil—urinary bladder cancer	0.0147	0.0197	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Etoposide—urinary bladder cancer	0.0142	0.019	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Cisplatin—urinary bladder cancer	0.014	0.0187	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Gemcitabine—urinary bladder cancer	0.0138	0.0185	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Fluorouracil—urinary bladder cancer	0.0136	0.0182	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Cisplatin—urinary bladder cancer	0.0129	0.0172	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Etoposide—urinary bladder cancer	0.0128	0.0171	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Carboplatin—urinary bladder cancer	0.0127	0.017	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Etoposide—urinary bladder cancer	0.0118	0.0158	CcSEcCtD
Sodium Tetradecyl Sulfate—Local reaction—Epirubicin—urinary bladder cancer	0.0113	0.0151	CcSEcCtD
Sodium Tetradecyl Sulfate—Local reaction—Doxorubicin—urinary bladder cancer	0.0105	0.014	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Valrubicin—urinary bladder cancer	0.0102	0.0136	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Valrubicin—urinary bladder cancer	0.01	0.0134	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Valrubicin—urinary bladder cancer	0.00951	0.0127	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Mitomycin—urinary bladder cancer	0.00943	0.0126	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Methotrexate—urinary bladder cancer	0.00852	0.0114	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Epirubicin—urinary bladder cancer	0.00797	0.0107	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Methotrexate—urinary bladder cancer	0.00766	0.0103	CcSEcCtD
Sodium Tetradecyl Sulfate—Necrosis—Doxorubicin—urinary bladder cancer	0.00738	0.00987	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Epirubicin—urinary bladder cancer	0.00717	0.0096	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Methotrexate—urinary bladder cancer	0.00707	0.00946	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Mitomycin—urinary bladder cancer	0.00701	0.00938	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Mitomycin—urinary bladder cancer	0.00691	0.00924	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Methotrexate—urinary bladder cancer	0.00669	0.00895	CcSEcCtD
Sodium Tetradecyl Sulfate—Extravasation—Doxorubicin—urinary bladder cancer	0.00664	0.00888	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Epirubicin—urinary bladder cancer	0.00662	0.00885	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Mitomycin—urinary bladder cancer	0.00655	0.00877	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Epirubicin—urinary bladder cancer	0.00626	0.00838	CcSEcCtD
Sodium Tetradecyl Sulfate—Ulcer—Doxorubicin—urinary bladder cancer	0.00612	0.00819	CcSEcCtD
Sodium Tetradecyl Sulfate—Pulmonary embolism—Doxorubicin—urinary bladder cancer	0.00579	0.00775	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Thiotepa—urinary bladder cancer	0.00474	0.00635	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00466	0.00624	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00459	0.00614	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Thiotepa—urinary bladder cancer	0.0044	0.0059	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00435	0.00582	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00409	0.00547	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Gemcitabine—urinary bladder cancer	0.00399	0.00534	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00398	0.00533	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Fluorouracil—urinary bladder cancer	0.00392	0.00525	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Cisplatin—urinary bladder cancer	0.00372	0.00498	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Fluorouracil—urinary bladder cancer	0.00364	0.00488	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Thiotepa—urinary bladder cancer	0.00353	0.00472	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Thiotepa—urinary bladder cancer	0.00347	0.00465	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Etoposide—urinary bladder cancer	0.00341	0.00456	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00338	0.00452	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Thiotepa—urinary bladder cancer	0.00329	0.00441	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.0032	0.00429	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Etoposide—urinary bladder cancer	0.00316	0.00423	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Gemcitabine—urinary bladder cancer	0.00297	0.00397	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Etoposide—urinary bladder cancer	0.00293	0.00393	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Gemcitabine—urinary bladder cancer	0.00292	0.00391	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Fluorouracil—urinary bladder cancer	0.00292	0.0039	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Fluorouracil—urinary bladder cancer	0.00287	0.00385	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Gemcitabine—urinary bladder cancer	0.00277	0.00371	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Cisplatin—urinary bladder cancer	0.00276	0.0037	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Fluorouracil—urinary bladder cancer	0.00272	0.00365	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Cisplatin—urinary bladder cancer	0.00258	0.00346	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Etoposide—urinary bladder cancer	0.00253	0.00339	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Etoposide—urinary bladder cancer	0.0025	0.00334	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00239	0.00319	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Etoposide—urinary bladder cancer	0.00237	0.00317	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00223	0.00299	CcSEcCtD
Sodium Tetradecyl Sulfate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00207	0.00276	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Methotrexate—urinary bladder cancer	0.00204	0.00273	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Epirubicin—urinary bladder cancer	0.00191	0.00256	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Methotrexate—urinary bladder cancer	0.0019	0.00254	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Epirubicin—urinary bladder cancer	0.00177	0.00237	CcSEcCtD
Sodium Tetradecyl Sulfate—Pain—Doxorubicin—urinary bladder cancer	0.00177	0.00236	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00176	0.00235	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00164	0.0022	CcSEcCtD
Sodium Tetradecyl Sulfate—Urticaria—Doxorubicin—urinary bladder cancer	0.00164	0.0022	CcSEcCtD
Sodium Tetradecyl Sulfate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00152	0.00204	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Methotrexate—urinary bladder cancer	0.00152	0.00203	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Methotrexate—urinary bladder cancer	0.00149	0.002	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Epirubicin—urinary bladder cancer	0.00142	0.0019	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Methotrexate—urinary bladder cancer	0.00142	0.0019	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Epirubicin—urinary bladder cancer	0.0014	0.00187	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Epirubicin—urinary bladder cancer	0.00133	0.00177	CcSEcCtD
Sodium Tetradecyl Sulfate—Vomiting—Doxorubicin—urinary bladder cancer	0.00131	0.00176	CcSEcCtD
Sodium Tetradecyl Sulfate—Headache—Doxorubicin—urinary bladder cancer	0.00129	0.00173	CcSEcCtD
Sodium Tetradecyl Sulfate—Nausea—Doxorubicin—urinary bladder cancer	0.00123	0.00164	CcSEcCtD
